We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mild Electric Current Disrupts Bacterial Biofilms

By HospiMedica International staff writers
Posted on 15 Dec 2016
A novel wound-healing technology uses an electrochemical scaffold (e-scaffold) and enhanced antibiotic susceptibility to eradicate biofilms and persister cells.

Researchers at Washington State University (Spokane, WA, USA) used an e-scaffold made out of conductive carbon fabric and a mild electrical current to produce a low, constant concentration of hydrogen peroxide (H2O2, an effective disinfectant) at the e-scaffold surface. More...
The H2O2 disrupts the biofilm matrix and damages the bacteria cell walls and DNA, which allows better antibiotic penetration and efficacy against subpopulations of persister cells that survive treatment and are able to grow and multiply, resulting in chronic infections.

The researchers found that the e-scaffold enhanced tobramycin susceptibility in P. aeruginosa biofilms, which reached a maximum susceptibility at 40 µg/ml tobramycin, leading to complete elimination. In addition, the e-scaffold eradicated persister cells in the biofilms, leaving no viable cells. The researchers also observed that the e-scaffold induced intracellular formation of hydroxyl free radicals and improved membrane permeability in biofilm cells, which possibly enhanced the antibiotic susceptibility and eradication of persister cells. The study was published on November 23, 2016, in npj Biofilms and Microbiomes.

“Similar to the way that penicillin was discovered by accident, the research to develop the e-scaffold actually came out of a failed attempt to improve fuel cells,” said lead author Professor Haluk Beyenal, PhD, of the WSU School of Chemical Engineering and Bioengineering. “As engineers, we are always trying to find solutions to a problem, so we decided to use bad cathodes to control biofilm growth, and it worked. Our inspiration came from the fundamental work to understand its mechanism.”

Biofilms protect bacterial communities in part because the extracellular polymeric substances (EPS) that form the biofilm matrix serve as a diffusion barrier that limits antibiotic penetration and immobilizes antibiotics. The diffusive barrier also results in nutrient gradients, causing decreased growth and metabolic inactivity in parts of the biofilm community, which allows persister cells to arise. Increased persister cell formation is particularly observed in Gram-negative bacterial biofilms, as their cell membranes are composed of lipopolysaccharides that further limit antibiotic penetration.

Related Links:
Washington State University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.